Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

A patient's grey hair regained color during treatment with adalimumab.

Some antidepressants can cause rare hair loss, which can significantly affect patients' well-being.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

PMC shows promise as a treatment for hair loss.

Potassium channel openers like minoxidil help hair grow by acting on hair follicles.

Gray hair can potentially be reversed, leading to new treatments.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The new system can grow hair in the lab and test hair growth treatments.

Nilotinib may cause gray hair to return to its original color.

Valproic Acid helps regrow hair in mice and activates a hair growth marker in human cells.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.